Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00353470
Status:
COMPLETED
Last Update Posted:
2022-12-23
First Post:
2006-07-14
Brief Title:
Comparison of Psychotherapy Programs to Treat Panic Disorder
Sponsor:
Weill Medical College of Cornell University
Organization:
Weill Medical College of Cornell University
Study Overview
Official Title:
Dynamic Treatment vs CBT for Panic Disorder
Status:
COMPLETED
Status Verified Date:
2022-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will determine the relative effectiveness of three psychotherapies in treating people with a panic disorder
Detailed Description:
Panic disorder PD is a debilitating anxiety disorder It is characterized by unexpected and repeated episodes of intense fear accompanied by serious physical symptoms such as chest pain heart palpitations shortness of breath dizziness or abdominal stress Available treatments for PD include medication therapy and cognitive behavioral therapy CBT a type of psychotherapy that teaches people how to view panic attacks differently and how to reduce anxiety Approximately 30 of patients refuse medication however and nearly 50 do not achieve remission with CBT alone Therefore there is a pressing need for additional non-pharmacologic treatment methods Panic-focused psychodynamic psychotherapy PFPP and applied relaxation training ART are among some of the other available treatments for PD During ART individuals are taught to relax their muscles while being exposed to increasingly frightening situations PFPP combines elements of CBT with other more extensive approaches aimed at determining the anxietys origin and at finding ways to reduce it This study will compare the effectiveness of PFPP CBT and ART in treating PD
Participants in this single blind study will be randomly assigned to receive PFPP CBT or ART for 12 weeks All participants will attend between 19 and 24 treatment sessions over the course of the study Upon completing the study participants will attend monthly follow-up visits for an additional 12 months Participants assigned to ART who have not responded by the end of treatment may opt to receive PFPP or CBT Outcomes will be assessed using a variety of scales to determine depression and anxiety symptoms
Participants in this single blind study will be randomly assigned to receive PFPP CBT or ART for 12 weeks All participants will attend between 19 and 24 treatment sessions over the course of the study Upon completing the study participants will attend monthly follow-up visits for an additional 12 months Participants assigned to ART who have not responded by the end of treatment may opt to receive PFPP or CBT Outcomes will be assessed using a variety of scales to determine depression and anxiety symptoms
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01MH070664 | NIH | None | httpsreporternihgovquickSearchR01MH070664 |